What is Decoy Therapeutics Inc.?
operates as a pre-clinical stage biotechnology company.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.98M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.